Stacy Chin explains how a policy vacuum froze federal startup funding through NIH, NSF, and DOD programs, forcing founders to pause and investors to hold deals. Congress passed HR 1500 in September 2025, giving agencies one year to resume solicitations and restore confidence in the pipeline.
Chapters
Now, what's going on with startup founders across the nation? They're left in limbo, staring at the deadlines, not knowing when the next funding round's gonna come even next. I've talked to teams who have proposals ready to go, budgets filled, partners lined up, but then they froze. Why pour months into an application if the entire program is going to vanish? So startups have been pausing submissions. Investors held off on term sheets, waiting to see if federal funding would dry up. Even agencies like the NIH, the NSF, the DOD were caught in the middle, unsure whether to release new solicitations or put everything on hold. So for small companies relying on the SBIR and STTR programs as their lifeline, that uncertainty wasn't just inconvenient, but rather existential. But here's the thing. While policymakers argue about performance metrics and oversight, founders weren't thinking about the policy. They're thinking about survival, how to keep the labs open, how to keep the engineers and scientists paid, how to keep the ideas alive in a system that can feel like it vanishes overnight. And that's where HR 5100 comes in. So in mid-September 2025, Congress Congress finally stepped in and passed a short technical bill quietly but critically called HR 1500. And this is why it matters. This bill gives founders one year on clarity to submit agency confidence, solicit any awards, and investors enough certainty to continue pushing deals forward.